CVRx Inc (CVRX)
Healthcare
Medical Devices
5.20 $
-3.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns CVRx Inc (CVRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.1% of the shares are freely tradable; institutional investors hold 63.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
63.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
9.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
69.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
9.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
27Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Johnson & Johnson | 15.17 | 4,024,861 | +0.0 | 03/31/2026 |
| NEA Management Company, LLC | 7.64 | 2,026,083 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.22 | 1,120,663 | +2.8 | 12/31/2025 |
| BlackRock Inc | 3.87 | 1,026,559 | -3.3 | 03/31/2026 |
| GSK PLC | 3.80 | 1,007,583 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.43 | 911,310 | +0.0 | 03/31/2026 |
| Royal Bank of Canada | 2.66 | 706,950 | +6,559.3 | 03/31/2026 |
| Balyasny Asset Management LLC | 2.38 | 630,812 | -22.6 | 03/31/2026 |
| Silvercrest Asset Management Group LLC | 2.16 | 572,021 | -9.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.58 | 684,121 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.